CABOSUN trial of cabozantinib - could it change how we treat frontline RCC?
News from ASCO 2016 for melanoma
The importance of the Phase III JAVELIN LUNG 100 trial in non-small-cell lung cancer
The resurgence of immunotherapy in the treatment of cancer
Increasing overall survival in oligometastatic lung cancer patients